tiprankstipranks
Trending News
More News >
Genmab A/S (GMAB)
NASDAQ:GMAB

Genmab (GMAB) Similar Stocks

Compare
740 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Genmab
$31.71
$19.22B
13.36
57.84%
5 Buy
2 Hold
0 Sell
Moderate Buy
BioMarin Pharmaceutical
$51.80
$9.95B
19.41
-19.93%
14 Buy
5 Hold
0 Sell
Moderate Buy
Incyte
$97.63
$19.05B
16.38
44.53%
9 Buy
8 Hold
1 Sell
Moderate Buy
Ascendis Pharma
$202.82
$12.96B
-47.75
49.46%
14 Buy
0 Hold
0 Sell
Strong Buy
BioNTech SE
$91.60
$22.18B
-19.80%
12 Buy
3 Hold
0 Sell
Strong Buy
Royalty Pharma
$38.31
$22.16B
21.95
60.49%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GMAB
Genmab
31.71
11.62
57.84%
BMRN
BioMarin Pharmaceutical
51.80
-13.20
-20.31%
INCY
Incyte
97.63
30.57
45.59%
ASND
Ascendis Pharma
202.82
65.08
47.25%
BNTX
BioNTech SE
91.60
-19.74
-17.73%
RPRX
Royalty Pharma
38.31
14.63
61.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts